Japan launches Fine Granule Formulation of Anti-epileptic Drug Fycompa

Eisai Co., Ltd. announced on 6 July 2020 that it has launched a new fine granule formulation of its in-house-discov...

July 6, 2020 | Monday | News
Eisai launches anti-insomnia drug in Japan

Japanese firm Eisai Co., Ltd. announced that it has launched its in-house-discovered and developed orexin receptor antag...

July 8, 2020 | Wednesday | News
Hitachi, ThinkCyte focus on AI-driven cell analysis and sorting system

Japan based companies Hitachi, Ltd. and ThinkCyte, Inc. have announced that they have entered into a collaboration focus...

July 7, 2020 | Tuesday | News
Fujifilm, Dr. Reddy and Global Response Aid to co-develop anti COVID-19 drug

FUJIFILM Corporation partners with Dr. Reddy’s Laboratories Ltd., a global pharmaceutical company headquartered in...

July 3, 2020 | Friday | News
Eisai joins REMAP-CAP on innovative trial to combat COVID-19

US based Global Coalition for Adaptive Research and Japanese firm Eisai Co., Ltd., in collaboration with UPMC (Universit...

July 6, 2020 | Monday | News
Japan begins research on vitals measurement headset

Kyocera Corporation and Tokyo Medical and Dental University (TMDU) announced a joint research project to develop a wirel...

July 3, 2020 | Friday | News
Daiichi Sankyo in discussion with AZ for COVID-19 vaccine supply

Japan based Daiichi Sankyo Company, Limited has announced its agreement to proceed with discussions with AstraZeneca for...

July 2, 2020 | Thursday | News
Japan reveals breakthrough research in cancer

Researchers in Japan claim that they have replicated cancer cells from diseased bladder tissue in dogs, minimizing the u...

July 1, 2020 | Wednesday | News
Japan repurposes hypertension vaccine for COVID-19 treatment

The Osaka-based Japanese biotech AnGes Inc. expects its potential COVID-19 vaccine to be ready as early as the first hal...

June 29, 2020 | Monday | News
Japan develops saliva test to detect COVID-19 in 30-min

Nihon University and Tokyo Medical University are developing a novel RT-PCR method for detection of SARS-CoV2 virus. Unl...

June 26, 2020 | Friday | News
Thermo Fisher, Daiichi Sankyo to co-develop CDx for NSCLC

Thermo Fisher Scientific and Daiichi Sankyo have expanded their partnership by signing a new agreement to co-develo...

June 30, 2020 | Tuesday | News
Cardiovascular disease (CVD) impact on Asia-Pacific markets

HONG KONG Prevalence CVD, including heart attack and stroke, is the third leading cause of death in Hong Kong (aft...

June 23, 2020 | Tuesday | Analysis
EIU launches APAC Economist Intelligence Unit report for heart ailments

  The Cost of Inaction: Secondary Prevention of Cardiovascular Disease in Asia-Pacific   Rehabilitation ...

June 23, 2020 | Tuesday | News
Daiichi Sankyo to develop mRNA vaccine against COVID-19

Daiichi Sankyo Company, Limited has announced its decision to develop a genetic (mRNA) vaccine for the novel corona viru...

June 23, 2020 | Tuesday | News
Japan develops breakthrough treatment for osteoarthritis

A break through feat of growing pluripotency expressing cells from osteoarthritis (OA) affected cartilage tissue of knee...

June 24, 2020 | Wednesday | News
Santen, Orbis to develop training tools for eye care

Japanese firm Santen Pharmaceutical Co., Ltd. and US based Orbis International have announced a partnership to develop a...

June 25, 2020 | Thursday | News
Joimax develops partnership with Japan Medicalnext

Joimax, the German based market leader in technologies and training methods for full-endoscopic and minimally invasive s...

June 22, 2020 | Monday | News
Japan studies genetic differences of COVID-19 and SARS viruses

Researchers at the University of Tokyo in Japan have identified specific portions of the genetic codes of the COVID-19 a...

June 19, 2020 | Friday | News